Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis

Παρόμοια τεκμήρια

• Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
  ανά: Wang, Huan, κ.ά.
  Έκδοση: (2014)
• Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers.
  ανά: Offin, Michael, κ.ά.
  Έκδοση: (2018)
• EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
  ανά: Yang, Jiyoul, κ.ά.
  Έκδοση: (2018)
• BRIEF REPORT: Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors
  ανά: Kobayashi, Susumu, κ.ά.
  Έκδοση: (2013)
• Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
  ανά: Suda, Kenichi, κ.ά.
  Έκδοση: (2021)